3B BlackBio Dx Ltd approves Q2 FY27 results, reporting consolidated revenue of ₹48.28 crore
- Revenue rose 42.4% year on year and 44.2% sequentially; net profit was ₹18.02 crore, up 19.8% year on year and 100.7% sequentially.
- Calculated operating margin was 40.7%; no exceptional items were reported.
- Auditors’ limited review found no material misstatement; subsidiary interim results were not independently reviewed by their auditors.
